Acta Med. 2018, 61: 93-97

https://doi.org/10.14712/18059694.2018.124

Evaluation of Risk Stratification Markers and Models in Acute Pulmonary Embolism: Rationale and Design of the MARS-PE (Mainz Retrospective Study of Pulmonary Embolism) Study Programme

Karsten Kellera,b, Johannes Beulec, Jörn Oliver Balzerd,e, Wolfgang Dippoldc

aCenter for Thrombosis and Hemostasis, University Medical Center Mainz, Johannes Gutenberg-University Mainz, Germany
bCenter of Cardiology, Department of Cardiology I, University Medical Center Mainz, Johannes Gutenberg-University Mainz, Germany
cDepartment of Internal Medicine, St. Vincenz and Elisabeth Hospital Mainz (KKM), Mainz, Germany
dDepartment of Diagnostic and Interventional Radiology, Catholic Clinic Mainz (KKM), Mainz, Germany
eDepartment of Diagnostic and Interventional Radiology, University Clinic, Johann Wolfgang Goethe-University Frankfurt/Main, Frankfurt, Germany

Received November 28, 2017
Accepted July 9, 2018

References

1. Konstantinides SV, Barco S, Rosenkranz S, et al. Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort study. J Thromb Thrombolysis 2016; 42: 600–9. <https://doi.org/10.1007/s11239-016-1415-7> <PubMed>
2. Konstantinides SV, Torbicki A, Agnelli G, et al., Task Force for the D and Management of Acute Pulmonary Embolism of the European Society of C. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35: 3033–69, 3069a–3069k. <https://doi.org/10.1093/eurheartj/ehu243>
3. Konstantinides S. Acute Pulmonary Embolism. N Engl J Med 2008; 359: 2804–13. <https://doi.org/10.1056/NEJMcp0804570>
4. Agnelli G and Becattini C. Acute pulmonary embolism. N Engl J Med 2010; 363: 266–74. <https://doi.org/10.1056/NEJMra0907731>
5. Keller K, Beule J, Schulz A, Dippold W. Troponin I as risk stratification marker in acute pulmonary artery embolism. Phlebologie 2013; 42: 261–9.
6. Keller K, Beule J, Balzer JO and Dippold W. Typical symptoms for prediction of outcome and risk stratification in acute pulmonary embolism. Int Angiol 2015.
7. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med 1992; 326: 1240–5. <https://doi.org/10.1056/NEJM199205073261902>
8. Sam A, Sanchez D, Gomez V, et al. The shock index and the simplified PESI for identification of low-risk patients with acute pulmonary embolism. Eur Respir J 2011; 37: 762–6. <https://doi.org/10.1183/09031936.00070110>
9. Jaff MR, McMurtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011; 123: 1788–830. <https://doi.org/10.1161/CIR.0b013e318214914f>
10. Chalikias GK, Tziakas DN, Stakos DA, Konstantinides SV. Managment of acute pulmonary embolism: a contemporary risk-tailored approach. Hellenic J Cardiol 2010; 51: 437–50.
11. Sanchez O, Trinquart L, Colombet I, et al. Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. Eur Heart J 2008; 29: 1569–77. <https://doi.org/10.1093/eurheartj/ehn208>
12. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008; 29: 2276–315. <https://doi.org/10.1093/eurheartj/ehn475>
13. Hsu JT, Chu CM, Chang ST, et al. Prognostic role of alveolar-arterial oxygen pressure difference in acute pulmonary embolism. Circ J 2006; 70: 1611–6. <https://doi.org/10.1253/circj.70.1611>
14. Goldhaber SZ. Assessing the prognosis of acute pulmonary embolism: tricks of the trade. Chest 2008; 133: 334–6. <https://doi.org/10.1378/chest.07-2464>
15. Giannitsis E, Muller-Bardorff M, Kurowski V, et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000; 102: 211–7. <https://doi.org/10.1161/01.CIR.102.2.211>
16. Schellhaass A, Walther A, Konstantinides S, Bottiger BW. The diagnosis and treatment of acute pulmonary embolism. Dtsch Arztebl Int 2010; 107: 589–95.
17. Jimenez D, Diaz G, Molina J, et al. Troponin I and risk stratification of patients with acute nonmassive pulmonary embolism. Eur Respir J 2008; 31: 847–53. <https://doi.org/10.1183/09031936.00113307>
18. Mikulewicz M, Lewczuk J. Importance of cardiac biomarkers in risk stratification in acute pulmonary embolism. Cardiol J 2008; 15: 17–20.
19. Keller K, Beule J, Schulz A, Coldewey M, Dippold W, Balzer JO. D-dimer for risk stratification in haemodynamically stable patients with acute pulmonary embolism. Adv Med Sci 2015; 60: 204–10. <https://doi.org/10.1016/j.advms.2015.02.005>
20. Ribeiro A, Lindmarker P, Juhlin-Dannfelt A, Johnsson H, Jorfeldt L. Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate. Am Heart J 1997; 134: 479–87. <https://doi.org/10.1016/S0002-8703(97)70085-1>
21. Ohigashi H, Haraguchi G, Yoshikawa S, et al. Comparison of biomarkers for predicting disease severity and long-term respiratory prognosis in patients with acute pulmonary embolism. Int Heart J 2010; 51: 416–20. <https://doi.org/10.1536/ihj.51.416>
22. Jimenez D, Uresandi F, Otero R, et al. Troponin-based risk stratification of patients with acute nonmassive pulmonary embolism: systematic review and metaanalysis. Chest 2009; 136: 974–82. <https://doi.org/10.1378/chest.09-0608>
23. Sanchez O, Trinquart L, Caille V, et al. Prognostic factors for pulmonary embolism: the prep study, a prospective multicenter cohort study. Am J Respir Crit Care Med 2010; 181: 168–73. <https://doi.org/10.1164/rccm.200906-0970OC>
24. Wu AH, Jaffe AS, Apple FS, et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem 2007; 53: 2086–96.
25. Hobohm L, Hellenkamp K, Hasenfuss G, Munzel T, Konstantinides S, Lankeit M. Comparison of risk assessment strategies for not-highrisk pulmonary embolism. Eur Respir J 2016; 47: 1170–8. <https://doi.org/10.1183/13993003.01605-2015>
26. Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation 2007; 116: 427–33. <https://doi.org/10.1161/CIRCULATIONAHA.106.680421>
27. Margato R, Carvalho S, Ribeiro H, Mateus P, Fontes P, Moreira JI. Cardiac troponin I levels in acute pulmonary embolism. Rev Port Cardiol 2009; 28: 1213–22.
28. Lankeit M, Jimenez D, Kostrubiec M, et al. Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism. Eur Respir J 2014; 43: 1669–77. <https://doi.org/10.1183/09031936.00211613>
29. Becattini C, Lignani A, Masotti L, Forte MB and Agnelli G. D-dimer for risk stratification in patients with acute pulmonary embolism. J Thromb Thrombolysis 2012; 33: 48–57. <https://doi.org/10.1007/s11239-011-0648-8>
30. Kreit JW. The impact of right ventricular dysfunction on the prognosis and therapy of normotensive patients with pulmonary embolism. Chest 2004; 125: 1539–45. <https://doi.org/10.1378/chest.125.4.1539>
31. Konstantinides S, Goldhaber SZ. Pulmonary embolism: risk assessment and management. Eur Heart J 2012.
32. Becattini C, Vedovati MC, Agnelli G. Right ventricle dysfunction in patients with pulmonary embolism. Intern Emerg Med 2010; 5: 453–5. <https://doi.org/10.1007/s11739-010-0435-0>
33. Kucher N, Rossi E, De Rosa M, Goldhaber SZ. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med 2005; 165: 1777–81. <https://doi.org/10.1001/archinte.165.15.1777>
34. Grifoni S, Olivotto I, Cecchini P, et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation 2000; 101: 2817–22. <https://doi.org/10.1161/01.CIR.101.24.2817>
35. Vieillard-Baron A, Page B, Augarde R, et al. Acute cor pulmonale in massive pulmonary embolism: incidence, echocardiographic pattern, clinical implications and recovery rate. Intensive Care Med 2001; 27: 1481–6. <https://doi.org/10.1007/s001340101032>
36. Fremont B, Pacouret G, Jacobi D, Puglisi R, Charbonnier B, de Labriolle A. Prognostic value of echocardiographic right/left ventricular end-diastolic diameter ratio in patients with acute pulmonary embolism: results from a monocenter registry of 1,416 patients. Chest 2008; 133: 358–62. <https://doi.org/10.1378/chest.07-1231>
37. Keller K, Beule J, Schulz A, Coldewey M, Dippold W, Balzer JO. Right ventricular dysfunction in hemodynamically stable patients with acute pulmonary embolism. Thromb Res 2014.
38. Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2015.
39. Steg PG, James SK and Gersh BJ. 2012 ESC STEMI guidelines and reperfusion therapy: Evidence-based recommendations, ensuring optimal patient management. Heart 2013; 99: 1156–7. <https://doi.org/10.1136/heartjnl-2013-304498>
40. Keller K, Beule J, Balzer JO and Dippold W. Right bundle branch block and SIQIII-type patterns for risk stratification in acute pulmonary embolism. J Electrocardiol 2016; 49: 512–8. <https://doi.org/10.1016/j.jelectrocard.2016.03.020>
41. Kucher N, Walpoth N, Wustmann K, Noveanu M, Gertsch M. QR in V1 – an ECG sign associated with right ventricular strain and adverse clinical outcome in pulmonary embolism. Eur Heart J 2003; 24: 1113–9. <https://doi.org/10.1016/S0195-668X(03)00132-5>
42. Klok FA, Cohn DM, Middeldorp S, et al. Quality of life after pulmonary embolism: validation of the PEmb-QoL Questionnaire. J Thromb Haemost 2010; 8: 523–32. <https://doi.org/10.1111/j.1538-7836.2009.03726.x>
43. Prandoni P. Links between arterial and venous disease. J Intern Med 2007; 262: 341–50. <https://doi.org/10.1111/j.1365-2796.2007.01815.x>
44. Prandoni P. Venous thromboembolism and atherosclerosis: is there a link? J Thromb Haemost 2007; 5 Suppl 1: 270–5. <https://doi.org/10.1111/j.1538-7836.2007.02467.x>
45. Hong C, Zhu F, Du D, Pilgram TK, Sicard GA, Bae KT. Coronary artery calcification and risk factors for atherosclerosis in patients with venous thromboembolism. Atherosclerosis 2005; 183: 169–74. <https://doi.org/10.1016/j.atherosclerosis.2005.03.047>
46. Klok FA, van der Hulle T, den Exter PL, Lankeit M, Huisman MV, Konstantinides S. The post-PE syndrome: a new concept for chronic complications of pulmonary embolism. Blood Rev 2014; 28: 221–6. <https://doi.org/10.1016/j.blre.2014.07.003>
47. Rasch B, Friese M, Hofmann W, Naumann E. Quantitative Methoden. Heidelberg: Springer; 2014.
48. Levine M, Ensom MH. Post hoc power analysis: an idea whose time has passed? Pharmacotherapy 2001; 21: 405–9. <https://doi.org/10.1592/phco.21.5.405.34503>
49. O’Keefe DJ. Brief Report: Post Hoc Power, Observed Power, A Priori Power, Retrospective Power, Prospective Power, Achieved Power: Sorting Out Appropriate Uses of Statistical Power Analyses. Communication Methods and Measures 2007; 1: 291–9. <https://doi.org/10.1080/19312450701641375>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive